Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shida Pan"'
Publikováno v:
Medicine, Vol 3, Iss 3, Pp 114-119 (2023)
Abstract. A recent study revealed that the inhibition of the farnesoid X receptor using ursodeoxycholic acid (UDCA) significantly reduces angiotensin-converting enzyme 2 (ACE2) expression. Therefore, considerable attention has been paid to the use of
Externí odkaz:
https://doaj.org/article/23a9dd6b951545f8b9d0b8c8ca2bfe2d
Autor:
Yaoru Song, Shida Pan, Jiahe Tian, Yingying Yu, Siyu Wang, Qin Qiu, Yingjuan Shen, Luo Yang, Xiaomeng Liu, Junqing Luan, Yilin Wang, Jianing Wang, Xing Fan, Fanping Meng, Fu-Sheng Wang
Publikováno v:
Biomedicines, Vol 12, Iss 6, p 1140 (2024)
(1) Background: Immune-related adverse events (irAEs) are a series of unique organ-specific inflammatory toxicities observed in patients with hepatocellular carcinoma (HCC) undergoing PD-1 inhibition combination therapy. The specific underlying mecha
Externí odkaz:
https://doaj.org/article/eb2a21d259844f159c0ffe7a3cab862d
Autor:
Yingying Yu, Siyu Wang, Nan Su, Shida Pan, Bo Tu, Jinfang Zhao, Yingjuan Shen, Qin Qiu, Xiaomeng Liu, Junqing Luan, Fu-Sheng Wang, Fanping Meng, Ming Shi
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundProgrammed cell death protein 1/programmed death-ligand 1 (PD-1/PD-L1) immune-related adverse events (irAEs) are inevitable in patients with liver cancer. Although the incidence of severe irAEs is low, but can result in fatal consequences.
Externí odkaz:
https://doaj.org/article/241ec6c613b24fcb99706271dca03126
Autor:
Shida Pan, Yingying Yu, Siyu Wang, Bo Tu, Yingjuan Shen, Qin Qiu, Xiaomeng Liu, Nan Su, Yanmei Zuo, Junqing Luan, Ji−Yuan Zhang, Ming Shi, Fanping Meng, Fu-Sheng Wang
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundThus far, few studies have investigated the safety and efficacy of programmed death-1 (PD-1) immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKIs) antibodies in patients with hepatitis B virus (HBV)-related liver cancer.
Externí odkaz:
https://doaj.org/article/b99d1068b9fe480f96bd094218744f59
Publikováno v:
Life Sciences. 182:80-84
ADP-ribosylation factor 6 (Arf6), a member of small GTPases ADP-ribosylation factor (Arf) family, expresses widely in mammalian cells and mainly regulates the functions of membrane traffic and actin remodeling. Current studies indicated that the acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd74f1b64db5684754ed297c3824acae
https://doi.org/10.1016/j.lfs.2017.06.008
https://doi.org/10.1016/j.lfs.2017.06.008